Timeline
Capucine Grandjean
Permanent Researcher
15 Aug 2025
publication
Reprogramming RIPK3-induced cell death in malignant B cells promotes immune-mediated tumor control.
Read more24 Feb 2025
01 Apr 2024
publication
Anti-PD-1 therapy triggers Tfh cell-dependent IL-4 release to boost CD8 T cell responses in tumor-draining lymph nodes.
Read more25 Mar 2024
news
New publication – Anti-PD-1 therapy triggers Tfh cell–dependent IL-4 release to boost CD8 T cell responses in tumor-draining lymph nodes
Read more01 Jul 2023
publication
Tumor-intrinsic sensitivity to the pro-apoptotic effects of IFN-γ is a major determinant of CD4+ CAR T-cell antitumor activity.
Read more05 Jun 2023
news
New publication – Tumor-intrinsic sensitivity to the pro-apoptotic effects of IFN-γ is a major determinant of CD4+ CAR T-cell antitumor activity
Read more02 Apr 2021
26 Mar 2021
publication
A cross-talk between CAR T cell subsets and the tumor microenvironment is essential for sustained cytotoxic activity.
Read more19 Feb 2021
01 Feb 2021
publication
Imaging the mechanisms of anti-CD20 therapy in vivo uncovers spatiotemporal bottlenecks in antibody-dependent phagocytosis.
Read more23 Oct 2019
publication
Tumor Immunosurveillance and Immunotherapies: A Fresh Look from Intravital Imaging.
Read more01 Apr 2019
publication
Single-cell imaging of CAR T cell activity in vivo reveals extensive functional and anatomical heterogeneity.
Read more06 Sep 2017
publication
Increased TCR signal strength in DN thymocytes promotes development of gut TCRαβ(+)CD8αα(+) intraepithelial lymphocytes.
Read more04 Oct 2016
publication
Intravital imaging reveals improved Kupffer cell-mediated phagocytosis as a mode of action of glycoengineered anti-CD20 antibodies.
Read more15 Jun 2015
11 May 2015